NORTHROP GRUMMAN CORP quarterly report, Q1 FY2024

Northrop Grumman Corporation 2024 First-Quarter Form 10-Q Summary

Business Context and Reporting Period

Northrop Grumman is an aerospace and defense technology company serving primarily the U.S. Department of Defense, intelligence community, and international customers. The filing covers the three months ended March 31, 2024, compared with the prior-year quarter. The interim financial statements were reviewed by Deloitte & Touche LLP and are unaudited.

Financial Performance and Liquidity

Metric	Q1 2024	Q1 2023	Change
Total sales	$10.133 billion	$9.301 billion	Up 9%
Operating income	$1.071 billion	$947 million	Up 13%
Operating margin	10.6%	10.2%	Up 40 basis points
Net earnings	$944 million	$842 million	Up 12%
Diluted EPS	$6.32	$5.50	Up 15%
Effective tax rate	16.5%	15.6%	Up 90 basis points
Cash used in operating activities	$(706) million	$(702) million	Comparable use
Free cash flow	$(976) million	$(1.011) billion	Improved $35 million

• Product sales increased 11% to $8.102 billion, while service sales were essentially unchanged at $2.031 billion.
• All four segments increased sales. Aeronautics Systems grew 18%, Defense Systems 3%, Mission Systems 4%, and Space Systems 9%.
• Segment operating income increased 10% to $1.104 billion, with a segment operating margin of 10.9% versus 10.8%.
• Net favorable estimate-at-completion adjustments were $94 million, compared with $46 million in the prior-year quarter.
• Cash and cash equivalents were $3.061 billion at March 31, 2024, compared with $3.109 billion at December 31, 2023.
• Long-term debt was $14.742 billion, up from $13.786 billion at year-end 2023. The company issued $2.5 billion of senior notes in January 2024.
• The company had no borrowings under its $2.5 billion credit facility or commercial paper program and was in compliance with debt covenants.
• Capital expenditures were $270 million. Financing activities provided $927 million, including $2.495 billion of debt proceeds, offset by $1.190 billion of share repurchases and $283 million of dividends paid.

Material Changes Versus the Prior Comparable Period

• Sales growth was led by higher product volume in restricted programs, F-35, E-2, SDA Tranche 2 Transport Layer, SiAW, GMLRS, and advanced microelectronics programs.
• Operating margin improved primarily from higher segment operating income and a more favorable FAS/CAS operating adjustment.
• The non-operating FAS pension benefit increased to $168 million from $132 million.
• Interest expense increased to $146 million from $129 million, reflecting higher debt levels.
• The diluted share count declined 3% to 149.3 million, supported by share repurchases. The company repurchased approximately 2.2 million shares during the quarter and had $2.4 billion remaining under its 2023 authorization.
• Backlog declined 6% from December 31, 2023 to $78.9 billion, primarily reflecting a $1.6 billion reduction in unfunded backlog following a termination for convenience in the restricted Space business. Approximately 40% of backlog is expected to convert to revenue within 12 months and 65% within 24 months.
• First-quarter net awards totaled $6.5 billion, including $3.1 billion for restricted programs.

Guidance, Outlook, Risks, Contingencies, and Unusual Items

• The filing does not provide a clear numerical full-year financial guidance range. Management expects the challenging macroeconomic environment, including inflation, labor constraints, supply-chain disruption, and higher interest rates, to continue affecting the company during 2024.
• Management expects the current cash balance, operating cash flow, and available credit and capital-market sources to provide sufficient short- and long-term liquidity. Cash flow is historically weighted toward the second half of the year.
• Cash from operations is expected to be reduced by approximately $350 million in 2024 because of the current IRC Section 174 requirement to amortize research and development costs, although legislation could change this impact.
• The B-21 low-rate initial production phase remains subject to a previously recorded projected loss of approximately $1.56 billion. The remaining loss accrual was $1.5 billion at March 31, 2024. Changes in costs, performance, quantities, funding, or supplier and customer negotiations could materially affect results.
• The HALO contract for NASA’s Lunar Gateway remains subject to negotiations over an engineering change proposal. An unfavorable outcome could adversely affect financial position, results, or cash flow.
• The Sentinel program is under a Nunn-McCurdy breach review due to increased cost estimates, particularly for construction and procurement. The production and deployment phases have not yet been priced and negotiated.
• The company faces a DOJ criminal subpoena and civil investigative demand, as well as a Defense Contract Management Agency interim determination of noncompliance, concerning interest-rate assumptions used in CAS pension accounting. The potential loss cannot currently be estimated and could be material.
• The company reported approximately $2.1 billion of unrecognized tax benefits, including $872 million related to IRC Section 451(b). Unfavorable resolution could materially affect future cash flows.
• Environmental remediation liabilities related primarily to Bethpage, New York, totaled $587 million accrued, with $381 million of reasonably possible future costs in excess of accrued amounts. The filing states that current identified projects are not expected to have a material adverse effect, but remediation costs may increase.
• Key broader risks include dependence on U.S. government funding, appropriations and contract awards; fixed-price contract cost growth; geopolitical developments; cyber threats; supplier and workforce constraints; regulatory and legal proceedings; environmental obligations; and pension and tax matters.

Important Facts Investors Should Verify

• Whether operating cash flow improves as expected in the second half of 2024 and whether working-capital balances, particularly unbilled receivables and inventory, normalize.
• Progress on reducing the B-21 LRIP loss accrual and the financial effects of supplier, customer, and funding developments.
• The outcome of the Sentinel Nunn-McCurdy review and its implications for future contract scope, pricing, and profitability.
• Developments in the DCMA and DOJ pension-accounting matters, including any potential financial exposure.
• Resolution of the HALO contract negotiations and the effect on Space Systems margins and backlog.
• Backlog quality and conversion, including the proportion that is funded and the impact of further terminations or delayed appropriations.
• Future tax cash payments under IRC Section 174 and developments regarding the company’s unrecognized tax benefits.
• Debt growth, interest expense, share repurchases, and the company’s ability to balance capital returns with liquidity and contract execution needs.